We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Trade Desk
TTD
$6.49B
| $29.7M | 0.06% |
+710,076
| New | +$38.9M |
|
327
Zillow
Z
$7.56B
| $29.7M | 0.06% |
936,809
+470,199
| +101% | +$18.9M |
|
|
NVRO
328
DELISTED
NEVRO CORP.
NVRO
| $29.7M | 0.06% |
677,090
+220,384
| +48% | +$12.1M |
|
329
PUT
Invesco QQQ Trust
QQQ
$484B
| $29.5M | 0.06% |
105,400
+95,500
| +965% | +$29.6M |
|
330
ArcelorMittal
MT
$55.3B
| $29.4M | 0.06% |
1,301,716
+931,790
| +252% | +$27.3M |
|
|
CHS
331
DELISTED
Chicos FAS, Inc.
CHS
| $29.3M | 0.06% |
5,901,872
+317,353
| +6% | +$1.6M |
|
|
CCXI
332
DELISTED
ChemoCentryx, Inc.
CCXI
| $29.2M | 0.06% |
1,178,948
-219,635
| -16% | -$4.84M |
|
|
GOOS
333
Canada Goose Holdings
GOOS
$856M
| $29.2M | 0.06% |
1,620,188
+569,065
| +54% | +$12M |
|
|
AXNX
334
DELISTED
Axonics, Inc. Common Stock
AXNX
| $29.2M | 0.06% |
514,693
-507,339
| -50% | -$27.8M |
|
335
ZIM Integrated Shipping Services
ZIM
$3.24B
| $29.1M | 0.06% |
616,942
-729,345
| -54% | -$42.8M |
|
336
LivaNova
LIVN
$4.2B
| $29.1M | 0.06% |
466,336
+4,607
| +1% | +$326K |
|
337
Endava
DAVA
$156M
| $29M | 0.06% |
328,549
-5,344
| -2% | -$559K |
|
|
PRPB
338
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
| $29M | 0.06% |
2,902,543
| – | – |
|
339
Western Union
WU
$2.21B
| $28.9M | 0.06% |
1,756,064
+318,015
| +22% | +$5.61M |
|
340
PUT
Tesla
TSLA
$1.3T
| $28.7M | 0.06% |
128,100
+101,400
| +380% | +$27.7M |
|
341
Copart
CPRT
$27.5B
| $28.4M | 0.06% |
1,044,720
-1,846,408
| -64% | -$52.6M |
|
342
Royal Caribbean
RCL
$85.6B
| $28.4M | 0.06% |
812,562
+703,661
| +646% | +$43.8M |
|
343
JD.com
JD
$44.5B
| $28.2M | 0.06% |
438,999
+380,498
| +650% | +$22M |
|
344
Kraft Heinz
KHC
$30B
| $28.2M | 0.06% |
+738,954
| New | +$29.6M |
|
345
PUT
Alibaba
BABA
$308B
| $28.2M | 0.06% |
247,700
+183,600
| +286% | +$18M |
|
346
Microchip Technology
MCHP
$46B
| $28.1M | 0.06% |
+483,569
| New | +$32M |
|
|
EOCW
347
DELISTED
Elliott Opportunity II Corp.
EOCW
| $27.8M | 0.06% |
2,857,509
+564,066
| +25% | +$5.5M |
|
348
Wheaton Precious Metals
WPM
$60.9B
| $27.7M | 0.06% |
770,157
+530,628
| +222% | +$23M |
|
|
DNB
349
DELISTED
Dun & Bradstreet
DNB
| $27.7M | 0.06% |
1,840,280
+470,706
| +34% | +$7.59M |
|
|
SLAM
350
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $27.6M | 0.06% |
2,813,848
| – | – |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.